×
About 373 results

ALLMedicine™ Allergy Immunotherapy Center

Research & Reviews  117 results

Determining the minimal important differences in the RQLQ score with grass and tree all...
https://doi.org/10.1111/all.15207
Allergy Blaiss MS, Juhl RG et. al.

Jan 6th, 2022 - Pollen from grasses and trees can trigger allergic rhinitis (AR), where the symptoms and associated consequences can negatively affect quality of life (QoL). The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) is frequently used in clinic...

Real-world evidence: Methods for assessing long term health and effectiveness of allerg...
https://doi.org/10.1016/j.jaci.2021.12.781
The Journal of Allergy and Clinical Immunology; Fritzsching B, Contoli M et. al.

Jan 2nd, 2022 - Real-world evidence: Methods for assessing long term health and effectiveness of allergy immunotherapy.|2022|Fritzsching B,Contoli M,Porsbjerg C,Buchs S,Larsen JR,|

Allergy immunotherapy from the patient's perspective.
https://doi.org/10.1002/alr.22898
International Forum of Allergy & Rhinology; Ballakur SS, An A et. al.

Sep 28th, 2021 - Allergy immunotherapy from the patient's perspective.|2021|Ballakur SS,An A,Toure M,Reisacher WR,|

Subcutaneous immunotherapy takes more than the time in the clinic.
https://doi.org/10.1080/03007995.2021.1976126
Current Medical Research and Opinion; Tankersley M, Winders T et. al.

Sep 8th, 2021 - The aim of this study was to investigate the time use and both direct and indirect costs associated with subcutaneous immunotherapy (SCIT) for adults with allergic rhinitis (AR) and caregivers of children with AR in the US. We conducted a survey t...

To mix or not to mix in allergy immunotherapy vaccines.
https://doi.org/10.1097/ACI.0000000000000784 10.1186/s13223-015-0109-6
Current Opinion in Allergy and Clinical Immunology; Nelson HS

Sep 4th, 2021 - European and US allergists generally do not agree on the approach to subcutaneous allergy immunotherapy in patients with multiple allergies. The North American approach is to treat with a mixture that contains all the allergen extracts to which th...

see more →

Clinicaltrials.gov  4 results

Allergy Immunotherapy for the Reduction of Asthma
https://clinicaltrials.gov/ct2/show/NCT01028560

May 28th, 2019 - In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who are at high risk for developing persisting asthma. These risk...

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
https://clinicaltrials.gov/ct2/show/NCT01469182

Mar 3rd, 2017 - This study assessed the safety profile of short ragweed (Ambrosia artemisiifolia) in participants with ragweed-induced rhinoconjunctivitis with or without asthma. The primary objective was to compare treatment-emergent adverse events (AEs) for par...

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet
https://clinicaltrials.gov/ct2/show/NCT01675791

Jan 22nd, 2014 - The primary aim of this trial is to evaluate the dose-response relationship for the ALK tree AIT administered once daily in order to define a dose-range that would be suitable for at-home administration.

Immunological Mechanisms of Allergy Immunotherapy
https://clinicaltrials.gov/ct2/show/NCT01914029

Aug 27th, 2013 - The process of immunization as a treatment for allergic disease brings about changes that are not all well understood and the understanding about them is developing constantly. In our study we plan to check a large number of immunological paramete...

see more →

News  28 results

Debate Continues Over Multiallergen Subcutaneous Immunotherapy
https://www.medscape.com/viewarticle/963870

Nov 30th, 2021 - A resolution is needed in the ongoing controversy between US and European allergists over the best approach to subcutaneous allergy immunotherapy (SCIT), "since it is likely that one or the other group of patients is receiving sub-optimal treatmen...

There's a Much Safer Food Allergy Immunotherapy. Why Don't More Doctors Offer It?
https://www.medscape.com/viewarticle/954302

Jul 7th, 2021 - This is part 1 of a three-part series. Part 2 is here. Part 3 is here. For the 32 million people in the United States with food allergies, those who seek relief beyond constant vigilance and EpiPens face a confusing treatment landscape. In January...

FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost
https://www.medscape.com/viewarticle/941016

Nov 15th, 2020 - Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it will be widely adopted has yet to be determined. A few dozen allergists aro...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.staging.medscape.com/viewarticle/928035

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.medscape.com/viewarticle/928035

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

see more →